CL2023001843A1 - Fumonisina conjugada para proteger contra la micotoxicosis. - Google Patents
Fumonisina conjugada para proteger contra la micotoxicosis.Info
- Publication number
- CL2023001843A1 CL2023001843A1 CL2023001843A CL2023001843A CL2023001843A1 CL 2023001843 A1 CL2023001843 A1 CL 2023001843A1 CL 2023001843 A CL2023001843 A CL 2023001843A CL 2023001843 A CL2023001843 A CL 2023001843A CL 2023001843 A1 CL2023001843 A1 CL 2023001843A1
- Authority
- CL
- Chile
- Prior art keywords
- mycotoxicosis
- fumonisin
- conjugated
- protect against
- protect
- Prior art date
Links
- 206010028520 Mycotoxicosis Diseases 0.000 title 1
- 231100000006 Mycotoxicosis Toxicity 0.000 title 1
- 239000003008 fumonisin Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Lubricants (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20216323 | 2020-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2023001843A1 true CL2023001843A1 (es) | 2024-03-08 |
Family
ID=73856710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2023001843A CL2023001843A1 (es) | 2020-12-22 | 2023-06-20 | Fumonisina conjugada para proteger contra la micotoxicosis. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240115685A1 (es) |
| EP (1) | EP4267189A1 (es) |
| JP (1) | JP2023554138A (es) |
| CN (1) | CN116940385A (es) |
| AU (1) | AU2021405229A1 (es) |
| CA (1) | CA3202815A1 (es) |
| CL (1) | CL2023001843A1 (es) |
| MX (1) | MX2023007538A (es) |
| WO (1) | WO2022136339A1 (es) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06321998A (ja) * | 1993-05-10 | 1994-11-22 | Kikkoman Corp | 抗フモニシンモノクローナル抗体、ハイブリドーマ、ハプテン抗原及びその製造法 |
-
2021
- 2021-12-21 AU AU2021405229A patent/AU2021405229A1/en active Pending
- 2021-12-21 CN CN202180087052.5A patent/CN116940385A/zh active Pending
- 2021-12-21 JP JP2023537666A patent/JP2023554138A/ja active Pending
- 2021-12-21 US US18/257,409 patent/US20240115685A1/en active Pending
- 2021-12-21 CA CA3202815A patent/CA3202815A1/en active Pending
- 2021-12-21 EP EP21843932.1A patent/EP4267189A1/en active Pending
- 2021-12-21 WO PCT/EP2021/086938 patent/WO2022136339A1/en active Application Filing
- 2021-12-21 MX MX2023007538A patent/MX2023007538A/es unknown
-
2023
- 2023-06-20 CL CL2023001843A patent/CL2023001843A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021405229A1 (en) | 2023-06-29 |
| CA3202815A1 (en) | 2022-06-30 |
| WO2022136339A1 (en) | 2022-06-30 |
| US20240115685A1 (en) | 2024-04-11 |
| CN116940385A (zh) | 2023-10-24 |
| EP4267189A1 (en) | 2023-11-01 |
| MX2023007538A (es) | 2023-07-10 |
| JP2023554138A (ja) | 2023-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015023976A3 (en) | Selective grp94 inhibitors and uses thereof | |
| BR112015030543A2 (pt) | glicerol formador de película para aplicação tópica | |
| UA113398C2 (xx) | Застосування антимікробіальних ефірних олій у водних композиціях | |
| WO2010092088A3 (de) | Verwendung von hydrophobin als spreitmittel | |
| CL2015000434A1 (es) | Metodo para el tratamiento, prevencion o disminucion de la severidad de una condicion o trastorno no neoplasico de la piel que comprende administrar un compuesto derivado de retinoides; composicion dermica que comprende los derivados de retinoide. | |
| WO2013185764A3 (en) | Pharmaceutical compositions for combination therapy | |
| CO2021002085A2 (es) | Composiciones de curcuminoides | |
| CL2020001273A1 (es) | Emulsiones para el tratamiento tópico de infecciones dérmicas y de infecciones de mucosas. | |
| MX2017001113A (es) | Composicion adhesiva. | |
| CL2023001843A1 (es) | Fumonisina conjugada para proteger contra la micotoxicosis. | |
| EA201500830A1 (ru) | Противогрибковая композиция для наружного применения для лечения онихомикоза | |
| CL2023001819A1 (es) | Zearalenona conjugada para proteger contra la micotoxicosis. | |
| EA032472B9 (ru) | Композиция для укладки волос | |
| CL2023001842A1 (es) | Aflatoxina b conjugada para proteger contra la micotoxicosis. | |
| FR3013985B1 (fr) | Compositions hydratantes comprenant au moins un extrait de caesalpinia spinosa, avec au moins de la vaseline et de la glycerine | |
| ES2973249T3 (es) | Composición que comprende cepa de Agathobaculum sp. como ingrediente efectivo para la prevención, alivio o tratamiento del trastorno del espectro autista | |
| CL2023001817A1 (es) | Toxina t-2 conjugada para proteger contra la mitocoxitosis. | |
| ES1299187Y (es) | Preparado para hacer gachas manchegas. | |
| DK3727404T3 (da) | Sammensætninger omfattende muslingelipidekstrakt og krillolie, og deres medicinske anvendelser | |
| MD20160039A2 (ro) | Metodă de tratament al onicomicozei cu hidroxipropil chitozan | |
| ES1261399Y (es) | Dispositivo de protección contra inundaciones. | |
| ES1241150Y (es) | Protector contra inclemencias del tiempo para patinete | |
| CL2023001798A1 (es) | Formulaciones coloidales de lignina-epoxi. | |
| ES1284981Y (es) | Dispositivo protector para árboles. | |
| CU24440B1 (es) | Composición farmacéutica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio |